# RELGAABI
> **ANDA204989** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2016-02-18
## Drug
- **FDA Application Number:** ANDA204989
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RELGAABI
- **Generic name:** GABAPENTIN
- **Active ingredients:** GABAPENTIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** ScieGen Pharmaceuticals, Inc.
- **First approval:** 2016-02-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204989)
---
*AI Analytics · CC0 1.0*